
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 天域生态2023年第二次临时股东大会会议资料 | 2023-02-10 | Chinese | |
| 天域生态关于提前归还部分暂时用于补充流动资金的闲置募集资金的公告 | 2023-02-02 | Chinese | |
| 天域生态2022年年度业绩预告 | 2023-01-30 | Chinese | |
| 关于天域生态环境股份有限公司非公开发行股票申请文件二次反馈意见的回复 | 2023-01-20 | Chinese | |
| 独立董事关于第四届董事会第七次会议相关议案的事前认可意见 | 2023-01-20 | Chinese | |
| 天域生态关于非公开发行股票方案调整及预案修订情况说明的公告 | 2023-01-20 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 38184212 | 天域生态2023年第二次临时股东大会会议资料 | 2023-02-10 | Chinese | ||
| 38184196 | 天域生态关于提前归还部分暂时用于补充流动资金的闲置募集资金的公告 | 2023-02-02 | Chinese | ||
| 38184180 | 天域生态2022年年度业绩预告 | 2023-01-30 | Chinese | ||
| 38184161 | 关于天域生态环境股份有限公司非公开发行股票申请文件二次反馈意见的回复 | 2023-01-20 | Chinese | ||
| 38184117 | 独立董事关于第四届董事会第七次会议相关议案的事前认可意见 | 2023-01-20 | Chinese | ||
| 38184108 | 天域生态关于非公开发行股票方案调整及预案修订情况说明的公告 | 2023-01-20 | Chinese | ||
| 38184097 | 天域生态关于非公开发行股票申请文件二次反馈意见回复的公告 | 2023-01-20 | Chinese | ||
| 38184081 | 天域生态第四届监事会第七次会议决议公告 | 2023-01-20 | Chinese | ||
| 38184070 | 众华会计师事务所(特殊普通合伙)关于天域生态环境股份有限公司非公开发行股票申请文件二次反馈意见的回复 | 2023-01-20 | Chinese | ||
| 38184050 | 中德证券有限责任公司关于天域生态环境股份有限公司非公开发行股票涉及关联交易事项的核查意见 | 2023-01-20 | Chinese | ||
| 38184023 | 天域生态环境股份有限公司非公开发行股票募集资金使用可行性分析报告(修订稿 | 2023-01-20 | Chinese | ||
| 38184009 | 天域生态关于签订附条件生效的股份认购协议之补充协议暨关联交易的公告 | 2023-01-20 | Chinese | ||
| 38183980 | 独立董事关于第四届董事会第七次会议相关议案的独立意见 | 2023-01-20 | Chinese | ||
| 38183928 | 天域生态环境股份有限公司非公开发行股票预案(修订稿) | 2023-01-20 | Chinese | ||
| 38183880 | 天域生态关于非公开发行股票摊薄即期回报与填补措施(修订稿)的的公告 | 2023-01-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.